• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by NCR Corporation (Amendment)

    2/13/24 5:09:42 PM ET
    $NCR
    Office Equipment/Supplies/Services
    Miscellaneous
    Get the next $NCR alert in real time by email
    SC 13G/A 1 tv01523-ncrvoyixcorp.htm SCHEDULE 13G/A ncrvoyixcorp

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 14)*

    Name of issuer:  NCR Voyix Corp

    Title of Class of Securities:  Common Stock

    CUSIP Number:  62886E108

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  62886E108

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    99,834

    7.  SOLE DISPOSITIVE POWER

    15,644,797

    8.  SHARED DISPOSITIVE POWER

    241,708

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    15,886,505

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    11.25%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    NCR Voyix Corp

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    864 Spring Street NW
    Atlanta, GA 30308

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    62886E108

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $NCR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NCR

    DatePrice TargetRatingAnalyst
    9/7/2023Buy → Neutral
    Northcoast
    9/19/2022$38.00 → $27.00Overweight → Equal-Weight
    Morgan Stanley
    11/19/2021$55.00Overweight
    Stephens & Co.
    8/4/2021$62.00 → $61.00Overweight
    Morgan Stanley
    More analyst ratings

    $NCR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NCR Corporation Changes Name to NCR Voyix Corporation

      NCR Corporation (NYSE:NCR), a leading enterprise technology provider, today announced a change of its name to NCR Voyix Corporation. This change reflects the company's planned separation into two independent, publicly traded companies, NCR Voyix, focused on digital commerce, and NCR Atleos, focused on ATMs. The separation is expected to be completed on October 16, 2023, at the close of business. The name change became effective on October 13, 2023. The company's stock will begin trading on the New York Stock Exchange under the new ticker symbol "VYX" on October 17, 2023. About NCR Corporation NCR Corporation (NYSE:NCR) is a leader in transforming, connecting and running technology pla

      10/16/23 6:00:00 AM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • NCR Atleos Set to Join S&P SmallCap 600

      NEW YORK, Oct. 11, 2023 /PRNewswire/ -- NCR Atleos Corp. (NYSE:NATL) will replace iTeos Therapeutics Inc. (NASD: ITOS) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 18. S&P MidCap 400 constituent NCR Corp. (NYSE:NCR) is spinning off NCR Atleos in a transaction expected to be completed on October 17. Following the spin-off, the NCR parent will have a name and symbol change to NCR Voyix Corp. (NYSE:VYX) and will remain in the S&P MidCap 400. iTeos Therapeutics is no longer representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Nam

      10/11/23 5:55:00 PM ET
      $ITOS
      $NCR
      $SPGI
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Office Equipment/Supplies/Services
      Miscellaneous
    • NCR Announces Boards of Directors for NCR Atleos and NCR Voyix following Separation

      NCR Atleos and NCR Voyix on track to become independent companies after close of business on October 16, 2023 NCR Corporation (NYSE:NCR), a leading enterprise technology provider, today announced the members of the boards of directors for NCR Atleos ("Atleos") and NCR Voyix ("Voyix") following the planned separation. This marks one of the final steps in the process to separate into two independent, publicly traded companies. Assuming completion of the separation, effective October 17, 2023, the new corporations will initiate trading under stock symbols, (NYSE:NATL) for Atleos and (NYSE:VYX) for Voyix. NCR Atleos The board of directors for Atleos will be comprised of executives across th

      10/11/23 5:30:00 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous

    $NCR
    Financials

    Live finance-specific insights

    See more
    • NCR Announces Second Quarter 2023 Results

      Strong First Half Pushes Expectations to Higher End of Previous Guided Ranges NCR Corporation (NYSE:NCR) reported financial results today for the three months ended June 30, 2023. Second quarter results and other recent highlights include: Revenue of $2.0 billion; Recurring revenue of $1.3 billion Net income from continuing operations attributable to NCR of $20 million Adjusted EBITDA of $389 million GAAP diluted EPS from continuing operations of $0.11; Non-GAAP diluted EPS of $0.94 Net cash provided by operating activities of $227 million; Adjusted free cash flow-unrestricted of $154 million Company progressing toward separation into two public companies "We delivere

      8/2/23 4:05:00 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • NCR Announces Second Quarter 2023 Earnings Conference Call

      NCR Corporation (NYSE:NCR) will release its second quarter 2023 financial results after the market close on Wednesday, August 2, 2023. A conference call is scheduled at 4:30 p.m. Eastern Time on the same day. Participants should plan to access the call 15 minutes prior to the start time to ensure a smooth connection. Details are as follows:     Dial in Number     Passcode     Time/Date Conference call   888-820-9413 (Tollfree) +1 786-460-7169 (Local) 9356480 4:30 p.m. Eastern, Aug. 2, 2023 The live conference call and related presentation materials will also be available at http://investor.

      7/19/23 8:00:00 AM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • NCR Announces Solid First Quarter 2023 Results

      Separation Into Two Leading Public Companies On Track NCR Corporation (NYSE:NCR) reported financial results today for the three months ended March 31, 2023. First quarter results and other recent highlights include: Revenue of $1.9 billion, up 1%; up 4% on a constant currency basis Recurring revenue of $1.2 billion, up 4% and up 7% on a constant currency basis Net income from continuing operations attributable to NCR of $9 million, up 127% Adjusted EBITDA of $302 million, up 11% and up 19% on a constant currency basis GAAP diluted EPS from continuing operations of $0.04, up 115% Non-GAAP diluted EPS of $0.56, up 6% Net cash provided by operating activities of $3

      5/4/23 4:05:00 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous

    $NCR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by NCR Corporation (Amendment)

      SC 13G/A - NCR VOYIX Corp (0000070866) (Subject)

      2/13/24 5:09:42 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • SEC Form SC 13G/A filed by NCR Corporation (Amendment)

      SC 13G/A - NCR CORP (0000070866) (Subject)

      11/10/22 11:21:21 AM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • SEC Form SC 13G/A filed by NCR Corporation (Amendment)

      SC 13G/A - NCR CORP (0000070866) (Subject)

      2/10/22 8:27:57 AM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous

    $NCR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Reddy Kevin Michael bought $100,312 worth of shares (6,250 units at $16.05), increasing direct ownership by 67% to 15,646 units (SEC Form 4)

      4 - NCR VOYIX Corp (0000070866) (Issuer)

      12/4/23 6:47:54 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • Kelly James G bought $995,100 worth of shares (64,200 units at $15.50), increasing direct ownership by 342% to 41,496 units (SEC Form 4)

      4 - NCR VOYIX Corp (0000070866) (Issuer)

      11/20/23 6:56:23 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous

    $NCR
    SEC Filings

    See more
    • SEC Form S-8 filed by NCR Corporation

      S-8 - NCR VOYIX Corp (0000070866) (Filer)

      12/20/23 4:06:01 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • NCR Corporation filed SEC Form 8-K: Leadership Update

      8-K - NCR VOYIX Corp (0000070866) (Filer)

      12/11/23 4:06:00 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • SEC Form 144 filed by NCR Corporation

      144 - NCR VOYIX Corp (0000070866) (Subject)

      11/15/23 1:36:43 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous

    $NCR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Tansill Brendan F

      4 - NCR VOYIX Corp (0000070866) (Issuer)

      2/5/24 7:49:19 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • SEC Form 4 filed by Tadele Beimnet

      4 - NCR VOYIX Corp (0000070866) (Issuer)

      2/5/24 7:48:39 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • SEC Form 3 filed by new insider Tansill Brendan F

      3 - NCR VOYIX Corp (0000070866) (Issuer)

      2/5/24 7:48:16 PM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous

    $NCR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • NCR Corp downgraded by Northcoast

      Northcoast downgraded NCR Corp from Buy to Neutral

      9/7/23 7:30:06 AM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • NCR Corp downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded NCR Corp from Overweight to Equal-Weight and set a new price target of $27.00 from $38.00 previously

      9/19/22 7:33:46 AM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous
    • Stephens & Co. initiated coverage on NCR with a new price target

      Stephens & Co. initiated coverage of NCR with a rating of Overweight and set a new price target of $55.00

      11/19/21 4:47:21 AM ET
      $NCR
      Office Equipment/Supplies/Services
      Miscellaneous

    $NCR
    Leadership Updates

    Live Leadership Updates

    See more
    • NCR Atleos Set to Join S&P SmallCap 600

      NEW YORK, Oct. 11, 2023 /PRNewswire/ -- NCR Atleos Corp. (NYSE:NATL) will replace iTeos Therapeutics Inc. (NASD: ITOS) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 18. S&P MidCap 400 constituent NCR Corp. (NYSE:NCR) is spinning off NCR Atleos in a transaction expected to be completed on October 17. Following the spin-off, the NCR parent will have a name and symbol change to NCR Voyix Corp. (NYSE:VYX) and will remain in the S&P MidCap 400. iTeos Therapeutics is no longer representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Nam

      10/11/23 5:55:00 PM ET
      $ITOS
      $NCR
      $SPGI
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Office Equipment/Supplies/Services
      Miscellaneous
    • Cumulus Media Appoints Deborah Farrington to Board of Directors

      ATLANTA, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (NASDAQ:CMLS) today announced that Deborah Farrington, Co-Founder and Managing Partner of StarVest Partners, LP, has been appointed to the Cumulus Media Board of Directors. "Deborah is a highly respected and accomplished venture capital pioneer and experienced board member of Fortune 500 and leading public technology companies," said Mary G. Berner, President and Chief Executive Officer of Cumulus Media. "As such, Deborah brings valuable strategic insights that will support the execution of our audio-first strategy and nicely complement our existing Board expertise. We are confident that Deborah's proven business acumen will be

      8/22/22 10:00:24 AM ET
      $CDAY
      $CMLS
      $NCR
      $RBAC
      EDP Services
      Technology
      Broadcasting
      Consumer Discretionary
    • JBT Corporation Appoints Robert Petrie as Executive Vice President and President, Protein

      CHICAGO, Sept. 24, 2021 /PRNewswire/ -- JBT Corporation (NYSE:JBT), a global technology solutions provider to high-value segments of the food and beverage industry, announced today the promotion of Robert "Bob" Petrie effective October 7th to the position of Executive Vice President and President, Protein. He succeeds Paul Sternlieb, who provided notice of his resignation from JBT in connection with his acceptance of the Chief Executive Officer position at an industrial public company, that is not competitive to JBT. Since 2016, Bob has led JBT's Protein EMEA (Europe, Middle East, and Africa) business, and at the start of this year assumed additional responsibility for JBT's Protein business

      9/24/21 9:00:00 AM ET
      $JBT
      $NCR
      Industrial Machinery/Components
      Industrials
      Office Equipment/Supplies/Services
      Miscellaneous